Value of Endomyocardial Biopsy in Infants, Children and Adolescents With Dilated or Hypertrophic Cardiomyopathy and Myocarditis
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Endomyocardial biopsy was performed in 20 symptomatic pediatric patients with the following clinical diagnoses: dilated cardiomyopathy in 16, hypertrophic cardiomyopathy in 2 and myocarditis in 2. Transfemoral biopsy was performed without complications in patients aged 2 months to 16 years; 6 were <1 year old. An average of five right ventricular specimens were obtained for histologic and ultrastructure study from each patient.
In 16 patients with the clinical diagnosis of dilated cardiomyopathy, biopsy findings were compatible with the diagnosis in 8, but changed the diagnosis as follows in the other 8: myocarditis, 4; hypertrophic cardiomyopathy, 2
Cardiomyopathy in childhood is a poorly understood disease process and is associated with cardiomegaly, progressive heart failure and early death (1) . This paper reports the results of a comprehensive prospective protocol to establish a definitive diagnosis in infants, children and adolescents presenting with the clinical diagnosis of cardiomyopathy or of myocarditis and assesses the value of endomyocardial biopsy in the management of these patients.
Methods
Study patients. A prospective study conducted over 2 years enrolled 20 newly evaluated infants, children and adolescents with the diagnosis of dilated or hypertrophic cardiomyopathy or myocarditis. These consecutive patients were symptomatic from congestive heart failure and subsequently admitted for evaluation. Asymptomatic patients and carnitine deficiency syndromes, 2. In two patients with the clinical diagnosis of hypertrophic cardiomyopathy, biopsy findings confirmed the diagnosis in one and were normal in the other who had an encapsulated cardiac fibroma at operation. In two patients with the clinical diagnosis of myocarditis, biopsy findings confirmed the diagnosis in one and suggested dilated cardiomyopathy in the other. In the entire series, 25 % had biopsy evidence of inflammatory disease. Biopsy findings were confirmed at subsequent autopsy in five cases.
(J Am Coil CardioI1988, '12:1547-54) seen for mild cardiomegaly that may have been due to myocarditis or mild cardiomyopathy were not enrolled. A history was obtained and physical examination, chest roentgenogram, electrocardiogram and echocardiogram were performed. Laboratory studies included the following: white blood count with differential; erythrocyte sedimentation rate; antinuclear antibody titer; nasopharyngeal and anal viral cultures; serum antibody titers for coxsackievirus A and B, adenovirus 1-7, influenza A-C, parainfluenza 1-3, cytomegalovirus, Epstein-Barr virus, chlamydia and mycoplasma pneumoniae. In half of the patients, skeletal muscle biopsy was performed at the end of the cardiac catheterization procedure to screen for carnitine deficiency syndromes. EndomyocardiaJ biopsy technique. All patients underwent right and left heart cardiac catheterization for hemodynamic assessment and endomyocardial biopsy. Angiography was performed after the biopsy. A Mullins transseptal sheath was modified with two holes made with a 23 gauge needle, 0.5 cm from the end of the transseptal sheath to increase the ease of aspiration through the sheath. The standard sheath that was placed percutaneously in a femoral vein was exchanged for a larger sheath through which the trans septal sheath could be easily manipulated with minimal patient discomfort or replaced if kinking occurred. Then a 6F or 7F transseptal sheath with an attached hemostasis valve was placed through the upgraded standard sheath and advanced to the right atrium. A balloon angiographic catheter was positioned in the right ventricular apex through the transseptal sheath. The balloon was used to anchor the catheter in the right ventricular apex. The transseptal sheath was advanced over the balloon catheter until a dampened ventricular pressure tracing was obtained. The balloon catheter was withdrawn and a similar sized Cordis disposable bioptome or Olympus bronchoscopy bioptome was advanced until the jaw mechanism extended just beyond the end of the sheath at the distal right ventricular septum. The C arm of the image intensifier was rotated to provide a 45° left anterior oblique projection. The sheath-bioptome combination was withdrawn slightly and rotated clockwise to direct the bioptome toward the distal septum. The jaws of the bioptome were opened and pressed against the right ventricular septum. The jaws were closed and a gentle tug was used to detach the specimens.
The specimens were fixed immediately. Before each specimen was obtained, care was taken to clean the bioptome in heparinized saline solution, to aspirate through the trans septal sheath and to reposition the trans septal sheath more proximally onto different right ventricular positions. No significant complications occurred in this patient series. One of 16 subsequent patients (not included in this study) died after cardiac tamponade secondary to inadvertent biopsy at the right ventricular septal-free wall junction.
Pathologic examination. Specimen size averaged 1 x 1 x 2 mm. Three to seven pieces, (mean five) were immersed in buffered 10% formalin for light microscopy. One to two specimens were immersed in 2% buffered glutaraldehyde for electron microscopy. One specimen was placed in viral and mycoplasma culture media. Paraffin sections were stained with hematoxylin-eosin, Masson trichrome, periodic acidSchiff and elastic van Gieson's stain. Each specimen was evaluated independently by two of us. A list of light and electron microscopy diagnostic characteristics was developed after reviewing previous investigators' experience (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . Characteristics were grouped to form criteria diagnostic of myocarditis and endocardial fibroelastosis and criteria suggestive of dilated and hypertrophic cardiomyopathy (Table 1) . Myocarditis criteria were in accordance with the Dallas Classification Conference (13) . For the diagnosis of myocarditis, mononuclear infiltrates seen on light microscopy typically consisted of lymphocytes and mononuclear cells clustered in the interstitium adjacent to damaged myocytes; no significant fibrosis was present and the intervening myocytes were normal (Fig. 1 ). In cases of dilated cardiomyopathy, interstitial fibrosis was used to indicate chronicity (Fig. 2) . Biopsy information was assessed by clinical cardiologists as 1) helpful in clinical management; 2) diagnostic of a disease process, or 3) leading to a change in patient management. 
Results
Clinical features and diagnoses ( Table 2 ). The study group consisted of 20 infants, children and adolescents, 10 female and 10 male. Age at biopsy ranged from 2 months to 15 years; six infants were < 1 year of age (mean and median age 69 and 39 months, respectively). Evidence of congestive heart failure was noted in 19 patients at the time of presentation and in 15 at the time of endomyocardial biopsy. One infant had evidence of severe right ventricular outflow tract obstruction without congestive peart failure. The duration of symptoms before endomyocardial biopsy was <2 weeks in 12 patients and <3 months in 17 (mean and median 7 months and < 2 weeks, respectively).
Two patients with myocarditis had positive nasopharyngeal viral cultures and increasing viral antibody titers specifying the viral agent. Cultured endomyocardial biopsy specimens did not show evidence of virus or other infective agents in any patient. One patient had a weakly positive antinuclear antibody titer in conjunction with maternal systemic lupus erythematosus. Two patients had a skeletal muscle biopsy assay diagnostic of a carnitine deficiency syndrome. Five patients had supraventricular or ventricular tachycardia; three of these patients with a medically well controlled chronic arrhythmia had dilated cardiomyopathy. The other two patients with an acute arrhythmia had biopsy evidence of myocardial inflammation.
Clinical diagnoses were as follows: dilated cardiomyopathy in 16, hypertrophic cardiomyopathy in 2 and myocarditis in 2. Endomyocardial biopsy diagnoses were asfollows: dilated cardiomyopathy in nine including one with endocardial fibroelastosis, hypertrophic cardiomyopathy in two, myocarditis in five including one with endocardial fibroelastosis , mitochondrial disorder diagnosed on electron microscopy in one and normal biopsy findings in three. Marked interstitial fibrosis was present in five patients with dilated cardiomyopathy, indicative of a chronic process. A high concordance did not exist between clinical and biopsy diagnoses ( Table 2) .
Clinical diagnosis versus biopsy diagnosis. Among the 16 patients with the clinical diagnosis of dilated cardiomyopathy, biopsy results were suggestive of dilated cardiomyopathy in 8 (50%). In the remaining eight patients with this clinical diagnosis , endomyocardial biopsy results were normal in two patients with a carnitine deficiency syndrome, and were suggestive of hypertrophic cardiomyopathy in two patients who presented with congestive heart failure, cardiomegaly, concentric wall hypertrophy, chamber dilatation and no evidence of outflow tract obstruction. With the use of both clinical and biopsy data, these two patients were CHF = congestive heart failure; DCM = dilated cardiomyopathy; EFE = endocardial fibroelastosis; F = female; HCM = hypertropic cardiomyopathy; M = male; RVOT = right ventricular outflow tract; SLE = systemic lupus erythematosus; SVT = supraventricular tachycardia; VT = ventricular tachycardia. diagnosed as having hypertrophic non obstructive cardiomyopathy (Fig. 3) . The biopsy diagnosis of myocarditis was made in the remaining 4 (25%) of the 16 patients with the clinical diagnosis of dilated cardiomyopathy. Three of these four patients with biopsy evidence of myocarditis could not be differentiated clinically from patients with the biopsy diagnosis of dilated cardiomyopathy, and one patient had predominantly neutrophilic infiltrates on biopsy associated with an autoimmune process of transplacental antinuclear antibodies from maternal systemic lupus erythematosus. Another patient with acute ventricular tachycardia and presumed dilated cardiomyopathy had diagnostic endomyocardial and skeletal muscle biopsy findings of clinically unsuspected sarcoidosis (14) (Fig. 4) .
The clinical diagnosis was hypertrophic cardiomyopathy in two patients. The first, a patient with severe right ventricular outflow tract obstruction, was the only patient in our series without signs of congestive heart failure. Endomyocardial biopsy results were normal, but surgical resection and histologic evaluation revealed normal myocardium covering an encapsulated fibroma. The second patient had presented in infancy with the clinical diagnoses of dilated cardiomyopathy and congestive heart failure. At the time of biopsy, clinical evidence suggested nonobstructive hypertrophic cardiomyopathy; electron microscopy, however, was diagnostic of a mitochondrial disorder with no characteristics of hypertrophic cardiomyopathy (Fig. 5) .
The clinical diagnosis of myocarditis was made in two patients. Endomyocardial biopsy was performed at different time intervals from the acute onset of the viral illness; in the patient with varicella 6 weeks after disappearance of the rash and in the patient with parainfluenza 5 days after onset of respiratory distress. In the patient with varicella, the biopsy showed no evidence of inflammatory cells and was suggestive of chronic dilated cardiomyopathy; whereas in the patient with parainfluenza, the biopsy showed evidence of myocarditis.
The clinical diagnosiS of endocardial fibroelastosis by echocardiography and angiography was made in addition to the diagnosis of cardiomyopathy in two patients. Endomyocardial biopsy confirmed the diagnosis only in one. The biopsy diagnosis of endocardial fibroelastosis, which was not detected clinically, was made in one patient with myocarditis.
Discussion
Endomyocardial biopsy studies in adults have demonstrated the utility of this technique (4, 15) . It is possible that studies in children will be more profitable in delineating the etiology and specific disease stages in patients with the clinical diagnosis of cardiomyopathy or myocarditis. There are few, primarily descriptive, reports of children with cardiomyopathy or myocarditis (16) (17) (18) . A paucity of centers worldwide have reported clinical experience with the endo myocardial biopsy technique in infants and children (2, (19) (20) (21) (22) (23) (24) (25) (26) , with Lurie et al. (22) (23) (24) having the longest experience.
Risks of endomyocardial biopsy. In our study, endomyocardial biopsy was performed as part of a prospective, comprehensive study of symptomatic infants, children and adolescents with the clinical diagnosis of cardiomyopathy or myocarditis. The endomyocardial biopsy technique was performed efficiently and safely in this study's 20 subjects as part of the routine cardiac catheterization procedure. In centers worldwide the complication rate has been < 1 % in adults (4, 25) . One death in a subsequent series of 16 patients occurred in a heparinized patient with a paper-thin ventricular free wall. We currently do not recommend heparinization during the endomyocardial biopsy. This complication indicates that the biopsy procedure still needs to be regarded as an invasive, diagnostic technique in which benefits must be weighed against the risks.
Pathologic accuracy of biopsy diagnoses. Pathologic evaluation showed that the endomyocardial biopsy technique produced an average of five specimens that were adequate for a light and electron microscopic study. With this number of specimens obtained, the rate of false negative biopsy diagnoses is low and probably similar to the 2% rate reported in adult studies (26) . In our series, surgical resection in one patient showed an encapsulated fibroma beneath the area accessible to endomyocardial biopsy that was missed on biopsy. Postmortem examination in 5 of the 20 patients during the 2 year study period confirmed the biopsy diagnosis in all (Table 2) . Extensive histologic sectioning in the three cases with the biopsy diagnosis of chronic dilated cardiomyopathy showed no evidence of biopsy-missed inflammatory cells. Autopsy sectioning in the case of sarcoidosis showed clusters of histiocytes with multinucleated giant cells detected by previous biopsy.
Usefulness of the endomyocardial biopsy material de-
pends on objective and skilled pathologists. Biopsy in related series was diagnostic of myocarditis (2) (3) (4) (5) (6) (7) (8) 13) , sarcoidosis (14, 27, 28) , endocardial fibroelastosis (11,12) and a mitochondrial disorder (29, 31) . Biopsy characteristics in our series (Table 1) were found to be highly suggestive of dilated JACC Vol. 12, No.6 December 1988 : 1547 or hypertrophic cardiomyopathy. The criteria for myocarditis depended on both light and electron microscopic evaluations. Electron micrographs were particularly helpful in confirming inflammatory cells and degenerative changes. Electron microscopy made the diagnosis of mitochondrial disorder, which was not detectable by light microscopy. It is also noteworthy that the only two normal biopsy specimens were from patients with a carnitine deficiency syndrome although lipid accumulation and mitochondrial alterations have been described with this disorder (32) (33) (34) . Thus, the pathologic evaluation of endomyocardial biopsy specimens can produce specific diagnoses, subclassify diagnoses and supply information suggesting the etiology of cardiomyopathies.
Clinical utility of endomyocardial biopsies. Endomyocardial biopsy was helpful in the diagnosis or management, or both, of the disease process in 75% of the 20 patients. Biopsy results were suggestive, but not pathognomonic, of dilated cardiomyopathy and hypertrophic cardiomyopathy. The biopsy was considered "diagnostic" in eight (40%) of the patients (or myocarditis in five, endocardial fibroelastosis in two, and a mitochondrial disorder in one patient). In addition to the diagnostic endomyocardial biopsy findings -in eight patients, skeletal muscle diagnosis of a treatable carnitine deficiency syndrome was made in two patients.
After assigning a biopsy diagnosis, the clinical value of this information in diagnosis and management of the 20 patients in the prospective study was assessed by the clinical cardiologist. The biopsy diagnoses were frequently different from the clinical diagnoses (Table 2) . Biopsy results affected clinical management in 10 (50%) of the patients. Immunosuppressive therapy was given to four patients with a biopsy diagnosis of myocarditis. The patient with a transplacental autoimmune process did not receive such therapy. Because the biopsy specimen showed no acute inflammatory process, immunosuppressive therapy was not administered in the patient with a history of varicella myocarditis. Digoxin administration was stopped in the two patients whose biopsy results suggested hypertrophic cardiomyopathy. Additional aggressive life-support therapy was not initiated in two patients with biopsy evidence of dilated cardiomyopathy, extensive fibrosis and degenerative changes suggesting a chronic end-stage disease process.
Myocarditis. Of particular interest were the five patients with a biopsy diagnosis of myocarditis. Four of our 16 patients with a clinical diagnosis of dilated cardiomyopathy and 1 of 2 patients with a clinical diagnosis of myocarditis had evidence of inflammation on biopsy. In our patients, as in other studies, rising antibody titers and culturing techniques (including myocardial tissue) failed to reliably diagnose myocarditis detected by biopsy. Endomyocardial biopsy is currently the most reliable means of diagnosing myocardial inflammation.
The proposed etiologies of l11yocarditis are varied, with viral infection and primary or secondary myocardial inflammation thought to be major causes (6, (35) (36) (37) (38) (39) . In patients with clinical evidence of acute myocarditis, it is probable that biopsy performed soon after the onset of symptoms will have a higher yield in detecting initial inflammatory changes. In a subset of patients with myocarditis the condition will progress to dilated cardiomyopathy (39) , as seen in our patient with varicella. Another group of patients who have clinical evidence of cardiomyopathy will have biopsy evidence of inflammation, possibly associated with an ongoing autoimmune process. A different inflammatory etiology is seen in our patient with antinuclear antibody-positive congenital complete heart block with dilated cardiomyopathy. This case suggests that a transplacental autoimmune inflammatory process may damage both neuronal and myocardial tissue (40) (41) (42) . The etiologic relation between arrhythmias and myocardial disease varies (43) (44) (45) (46) . In our study, an acute tachyarrhythmia was associated with myocarditis, whereas a chronic tachyarrhythmia was associated with chronic dilated cardiomyopathy. In regard to therapy, multicenter randomized trials in patients with endomyocardial biopsy evidence of myocarditis may show that immunosuppressive therapy can improve the currently poor prognosis (6, (37) (38) (39) (47) (48) (49) .
